Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Sjoquist KM"'
Publikováno v:
Biologics: Targets & Therapy, Vol 2015, Iss default, Pp 93-105 (2015)
Matthew MK Chan,1,2 Katrin M Sjoquist,1,3 John R Zalcberg4 1NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; 2Department of Medical Oncology, Central Coast Cancer Centre, Gosford Hospital, Gosford, NSW, Australia; 3Cancer C
Externí odkaz:
https://doaj.org/article/753dbcc498084cff88f458d9a9342066
Autor:
Werner B; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Sjoquist KM; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Espinoza D; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Yip S; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Chang G; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Cummins MM; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Mileshkin L; Peter MacCallum Cancer Centre, Melbourne, Australia., Ananda S; Peter MacCallum Cancer Centre, Melbourne, Australia; Western Health, Furlong Road, St Albans, Australia; Epworth Freemasons Hospital, East Melbourne, Australia; Department of Medicine, Western Health, University of Melbourne, Melbourne, Australia., Shannon C; Mater Cancer Care Centre, South Brisbane, Australia., Friedlander M; Prince of Wales Hospital, Sydney, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Warton K; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Ford CE; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. Electronic address: caroline.ford@unsw.edu.au.
Publikováno v:
Translational oncology [Transl Oncol] 2024 May; Vol. 43, pp. 101914. Date of Electronic Publication: 2024 Feb 27.
Autor:
Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Looze EJ; Division of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Thavaneswaran S; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., van Berge Henegouwen JM; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., van der Wijngaart H; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Sebastian L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands., Lin FP; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands., Thomas DM; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia., Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Oct 01; Vol. 153 (7), pp. 1413-1422. Date of Electronic Publication: 2023 Jul 10.
Autor:
Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia. Katrin.sjoquist@sydney.edu.au.; Cancer Care Centre, St George Hospital, Kogarah, Australia. Katrin.sjoquist@sydney.edu.au., Martin A; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia., Goldstein D; Prince of Wales Hospital, Sydney, Australia., Tsobanis E; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Moses D; Prince of Wales Hospital, Sydney, Australia.; Research Imaging NSW, UNSW, Sydney, Australia., Maher R; Radiology Department, Royal North Shore Hospital, Sydney, Australia., Hague W; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (8), pp. 4959-4965. Date of Electronic Publication: 2022 Oct 31.
Autor:
Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW 1450, Australia. Electronic address: katrin.sjoquist@sydney.edu.au.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 May; Vol. 24 (5), pp. 419-420. Date of Electronic Publication: 2023 Apr 17.
Autor:
Lam LL; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia. integrateii.study@sydney.edu.au., Pavlakis N; Royal North Shore Hospital, Sydney, Australia., Shitara K; National Cancer Centre Hospital East, Chiba, Japan., Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia., Martin AJ; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia., Yip S; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia., Kang YK; Asan Medical Centre, Seoul, South Korea., Bang YJ; Seoul National University College of Medicine, Seoul, South Korea., Chen LT; College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan., Moehler M; University Medical Centre Mainz, Mainz, Germany., Bekaii-Saab T; Mayo Clinic Comprehensive Cancer Centre, Phoenix, USA., Alcindor T; McGill University Health Centre, Montreal, Canada., O'Callaghan CJ; Olivia Newton-John Cancer Wellness & Research Centre, Melbourne, Australia., Tebbutt NC; Olivia Newton-John Cancer Wellness & Research Centre, Melbourne, Australia., Hague W; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia., Chan H; Calvary Mater Newcastle, Waratah, Australia., Rha SY; Yonsei Cancer Centre, Yonsei University Health System, Seoul, South Korea., Lee KW; Seoul National University College of Medicine, Seoul, South Korea.; Seoul National University Bundang Hospital, Seongnam, South Korea., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia., Jaworski A; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia., Zalcberg J; Monash University Melbourne, Melbourne, Australia., Price T; The Queen Elizabeth Hospital, Adelaide, Australia., Simes J; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia., Goldstein D; Prince of Wales Hospital, Sydney, Australia.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Feb 22; Vol. 23 (1), pp. 180. Date of Electronic Publication: 2023 Feb 22.
Autor:
Siu DHW; Department of Medical Oncology, Illawarra Shoalhaven Local Health District (ISLHD), New South Wales, Australia.; Department of Medical Oncology, St George Hospital, New South Wales, Australia.; National Health and Medical Research Council (NHMRC) Clinical Trial Centre, University of Sydney, New South Wales, Australia.; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Ali A; Department of Medical Oncology, Nelune Cancer Centre, The Prince of Wales Hospital (POWH), New South Wales, Australia.; Department of Medical Oncology, South Egypt Cancer Institute, Asyut, Egypt., Tjokrowidjaja A; Department of Medical Oncology, St George Hospital, New South Wales, Australia.; National Health and Medical Research Council (NHMRC) Clinical Trial Centre, University of Sydney, New South Wales, Australia., De Silva M; Department of Medical Oncology, Royal North Shore Hospital (RNSH), New South Wales, Australia., Lee J; Department of Medical Oncology, St George Hospital, New South Wales, Australia., Clingan PR; Department of Medical Oncology, Illawarra Shoalhaven Local Health District (ISLHD), New South Wales, Australia.; School of Medicine, University of Wollongong, New South Wales, Australia., Aghmesheh M; Department of Medical Oncology, Illawarra Shoalhaven Local Health District (ISLHD), New South Wales, Australia.; School of Medicine, University of Wollongong, New South Wales, Australia., Brungs D; Department of Medical Oncology, Illawarra Shoalhaven Local Health District (ISLHD), New South Wales, Australia.; School of Medicine, University of Wollongong, New South Wales, Australia., Mapagu C; Department of Medical Oncology, Illawarra Shoalhaven Local Health District (ISLHD), New South Wales, Australia.; Westmead Clinical School, University of Sydney, New South Wales, Australia., Goldstein D; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Department of Medical Oncology, Nelune Cancer Centre, The Prince of Wales Hospital (POWH), New South Wales, Australia., O'Neill S; Department of Medical Oncology, Nelune Cancer Centre, The Prince of Wales Hospital (POWH), New South Wales, Australia., Liauw WS; Department of Medical Oncology, St George Hospital, New South Wales, Australia.; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Sjoquist KM; Department of Medical Oncology, St George Hospital, New South Wales, Australia.; National Health and Medical Research Council (NHMRC) Clinical Trial Centre, University of Sydney, New South Wales, Australia., Thomas D; Department of Medical Oncology, St George Hospital, New South Wales, Australia., Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital (RNSH), New South Wales, Australia.; Northern Clinical School, University of Sydney, New South Wales, Australia., Clarke SJ; Department of Medical Oncology, Royal North Shore Hospital (RNSH), New South Wales, Australia.; Northern Clinical School, University of Sydney, New South Wales, Australia., Diakos C; Department of Medical Oncology, Royal North Shore Hospital (RNSH), New South Wales, Australia.; Northern Clinical School, University of Sydney, New South Wales, Australia., Chantrill LA; Department of Medical Oncology, Illawarra Shoalhaven Local Health District (ISLHD), New South Wales, Australia.; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; The Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Dec; Vol. 18 (6), pp. 660-668. Date of Electronic Publication: 2022 Jan 30.
Autor:
Woodford R; St George Hospital, Sydney, New South Wales, Australia., Brungs D; Illawarra Health and Medical Research Institute and School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.; Illawarra Cancer Care Centre, The Wollongong Hospital, Wollongong, New South Wales, Australia., Leighton C; Illawarra Cancer Care Centre, The Wollongong Hospital, Wollongong, New South Wales, Australia., Grimison P; Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia., Sjoquist KM; St George Hospital, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia., Becker T; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia., Robinson S; Illawarra Cancer Care Centre, The Wollongong Hospital, Wollongong, New South Wales, Australia., Gebski V; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia., Wilson K; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia., Chantrill L; Illawarra Cancer Care Centre, The Wollongong Hospital, Wollongong, New South Wales, Australia., Aghmesheh M; Illawarra Health and Medical Research Institute and School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.; Illawarra Cancer Care Centre, The Wollongong Hospital, Wollongong, New South Wales, Australia.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Oct; Vol. 18 (5), pp. e220-e226. Date of Electronic Publication: 2021 Jun 28.
Autor:
Samoon Z; The Crown Princess Mary Cancer Care Centre, Medical Oncology Clinical Trials Unit, Westmead Hospital, NSW, Australia., Naher SK; National Health and Medical Research Council Clinical Trials Centre (NHMRC CTC), University of Sydney, Campbelltown, NSW, Australia., Sjoquist KM; National Health and Medical Research Council Clinical Trials Centre (NHMRC CTC), University of Sydney, Campbelltown, NSW, Australia., Zalcberg J; Cancer Research Program, School of Public Health and Preventive Medicine, Faculty of Medicine, Monash University, Melbourne, Australia.
Publikováno v:
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2022 Apr; Vol. 23 (6), pp. 663-672. Date of Electronic Publication: 2022 Feb 23.